nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—Defaecation urgency—Mesalazine—Crohn's disease	0.111	0.111	CcSEcCtD
Rifaximin—Abdominal pain lower—Mesalazine—Crohn's disease	0.029	0.029	CcSEcCtD
Rifaximin—Rectal tenesmus—Mesalazine—Crohn's disease	0.0248	0.0248	CcSEcCtD
Rifaximin—Haematochezia—Mesalazine—Crohn's disease	0.0229	0.0229	CcSEcCtD
Rifaximin—Proctalgia—Mesalazine—Crohn's disease	0.0197	0.0197	CcSEcCtD
Rifaximin—Anorectal discomfort—Mesalazine—Crohn's disease	0.0169	0.0169	CcSEcCtD
Rifaximin—Upset stomach—Mesalazine—Crohn's disease	0.0141	0.0141	CcSEcCtD
Rifaximin—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0137	0.0137	CcSEcCtD
Rifaximin—Laryngeal pain—Mesalazine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Rifaximin—Dermatitis atopic—Mesalazine—Crohn's disease	0.0125	0.0125	CcSEcCtD
Rifaximin—Rhinorrhoea—Mesalazine—Crohn's disease	0.0114	0.0114	CcSEcCtD
Rifaximin—Proteinuria—Mesalazine—Crohn's disease	0.0105	0.0105	CcSEcCtD
Rifaximin—Protein urine present—Mesalazine—Crohn's disease	0.0104	0.0104	CcSEcCtD
Rifaximin—Bone disorder—Mesalazine—Crohn's disease	0.0102	0.0102	CcSEcCtD
Rifaximin—Colitis—Azathioprine—Crohn's disease	0.00972	0.00972	CcSEcCtD
Rifaximin—Neck pain—Mesalazine—Crohn's disease	0.00934	0.00934	CcSEcCtD
Rifaximin—Abnormal dreams—Mesalazine—Crohn's disease	0.00912	0.00912	CcSEcCtD
Rifaximin—Influenza like illness—Mesalazine—Crohn's disease	0.00896	0.00896	CcSEcCtD
Rifaximin—Colitis—Mesalazine—Crohn's disease	0.00886	0.00886	CcSEcCtD
Rifaximin—Ear pain—Mesalazine—Crohn's disease	0.00785	0.00785	CcSEcCtD
Rifaximin—Malnutrition—Mercaptopurine—Crohn's disease	0.00743	0.00743	CcSEcCtD
Rifaximin—Anaemia—Mercaptopurine—Crohn's disease	0.00687	0.00687	CcSEcCtD
Rifaximin—Dermatitis atopic—Prednisone—Crohn's disease	0.00659	0.00659	CcSEcCtD
Rifaximin—Migraine—Mesalazine—Crohn's disease	0.00659	0.00659	CcSEcCtD
Rifaximin—Arthralgia—Mercaptopurine—Crohn's disease	0.00633	0.00633	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00628	0.00628	CcSEcCtD
Rifaximin—Memory impairment—Prednisone—Crohn's disease	0.00622	0.00622	CcSEcCtD
Rifaximin—Abdominal pain upper—Mesalazine—Crohn's disease	0.00612	0.00612	CcSEcCtD
Rifaximin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00609	0.00609	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00603	0.00603	CcSEcCtD
Rifaximin—Nasopharyngitis—Mesalazine—Crohn's disease	0.00599	0.00599	CcSEcCtD
Rifaximin—Skin disorder—Mercaptopurine—Crohn's disease	0.00589	0.00589	CcSEcCtD
Rifaximin—Abdominal distension—Mesalazine—Crohn's disease	0.00583	0.00583	CcSEcCtD
Rifaximin—Dysphagia—Mesalazine—Crohn's disease	0.00579	0.00579	CcSEcCtD
Rifaximin—Anorexia—Mercaptopurine—Crohn's disease	0.00578	0.00578	CcSEcCtD
Rifaximin—Pneumonia—Azathioprine—Crohn's disease	0.0057	0.0057	CcSEcCtD
Rifaximin—Infestation NOS—Azathioprine—Crohn's disease	0.00567	0.00567	CcSEcCtD
Rifaximin—Infestation—Azathioprine—Crohn's disease	0.00567	0.00567	CcSEcCtD
Rifaximin—Contusion—Prednisone—Crohn's disease	0.00559	0.00559	CcSEcCtD
Rifaximin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00555	0.00555	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00553	0.00553	CcSEcCtD
Rifaximin—Dysuria—Mesalazine—Crohn's disease	0.00541	0.00541	CcSEcCtD
Rifaximin—Neutropenia—Mesalazine—Crohn's disease	0.00541	0.00541	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00538	0.00538	CcSEcCtD
Rifaximin—Pollakiuria—Mesalazine—Crohn's disease	0.00535	0.00535	CcSEcCtD
Rifaximin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00528	0.00528	CcSEcCtD
Rifaximin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00527	0.00527	CcSEcCtD
Rifaximin—Weight increased—Mesalazine—Crohn's disease	0.00527	0.00527	CcSEcCtD
Rifaximin—Weight decreased—Mesalazine—Crohn's disease	0.00524	0.00524	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00524	0.00524	CcSEcCtD
Rifaximin—Pneumonia—Mesalazine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Rifaximin—Infestation NOS—Mesalazine—Crohn's disease	0.00516	0.00516	CcSEcCtD
Rifaximin—Infestation—Mesalazine—Crohn's disease	0.00516	0.00516	CcSEcCtD
Rifaximin—Depression—Mesalazine—Crohn's disease	0.00515	0.00515	CcSEcCtD
Rifaximin—Haemoglobin—Azathioprine—Crohn's disease	0.00511	0.00511	CcSEcCtD
Rifaximin—Haemorrhage—Azathioprine—Crohn's disease	0.00509	0.00509	CcSEcCtD
Rifaximin—Haematuria—Mesalazine—Crohn's disease	0.00492	0.00492	CcSEcCtD
Rifaximin—Epistaxis—Mesalazine—Crohn's disease	0.00487	0.00487	CcSEcCtD
Rifaximin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00479	0.00479	CcSEcCtD
Rifaximin—Haemoglobin—Mesalazine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Rifaximin—Rhinitis—Mesalazine—Crohn's disease	0.00464	0.00464	CcSEcCtD
Rifaximin—Fluid retention—Prednisone—Crohn's disease	0.00463	0.00463	CcSEcCtD
Rifaximin—Haemorrhage—Mesalazine—Crohn's disease	0.00463	0.00463	CcSEcCtD
Rifaximin—Pharyngitis—Mesalazine—Crohn's disease	0.0046	0.0046	CcSEcCtD
Rifaximin—Mediastinal disorder—Azathioprine—Crohn's disease	0.00458	0.00458	CcSEcCtD
Rifaximin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00458	0.00458	CcSEcCtD
Rifaximin—Oedema peripheral—Mesalazine—Crohn's disease	0.00456	0.00456	CcSEcCtD
Rifaximin—Urethral disorder—Mesalazine—Crohn's disease	0.00454	0.00454	CcSEcCtD
Rifaximin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00447	0.00447	CcSEcCtD
Rifaximin—Tinnitus—Mesalazine—Crohn's disease	0.00432	0.00432	CcSEcCtD
Rifaximin—Angiopathy—Mesalazine—Crohn's disease	0.0042	0.0042	CcSEcCtD
Rifaximin—Mediastinal disorder—Mesalazine—Crohn's disease	0.00418	0.00418	CcSEcCtD
Rifaximin—Diarrhoea—Mercaptopurine—Crohn's disease	0.00415	0.00415	CcSEcCtD
Rifaximin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00411	0.00411	CcSEcCtD
Rifaximin—Anaemia—Azathioprine—Crohn's disease	0.00409	0.00409	CcSEcCtD
Rifaximin—Mental disorder—Mesalazine—Crohn's disease	0.00406	0.00406	CcSEcCtD
Rifaximin—Malaise—Azathioprine—Crohn's disease	0.00399	0.00399	CcSEcCtD
Rifaximin—Flatulence—Mesalazine—Crohn's disease	0.00397	0.00397	CcSEcCtD
Rifaximin—Back pain—Mesalazine—Crohn's disease	0.0039	0.0039	CcSEcCtD
Rifaximin—Muscle spasms—Mesalazine—Crohn's disease	0.00388	0.00388	CcSEcCtD
Rifaximin—Vomiting—Mercaptopurine—Crohn's disease	0.00386	0.00386	CcSEcCtD
Rifaximin—Rash—Mercaptopurine—Crohn's disease	0.00382	0.00382	CcSEcCtD
Rifaximin—Dermatitis—Mercaptopurine—Crohn's disease	0.00382	0.00382	CcSEcCtD
Rifaximin—Tremor—Mesalazine—Crohn's disease	0.00378	0.00378	CcSEcCtD
Rifaximin—Amnesia—Prednisone—Crohn's disease	0.00377	0.00377	CcSEcCtD
Rifaximin—Myalgia—Azathioprine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Rifaximin—Arthralgia—Azathioprine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00374	0.00374	CcSEcCtD
Rifaximin—Ill-defined disorder—Mesalazine—Crohn's disease	0.00374	0.00374	CcSEcCtD
Rifaximin—Anaemia—Mesalazine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Rifaximin—Discomfort—Azathioprine—Crohn's disease	0.00372	0.00372	CcSEcCtD
Rifaximin—Angioedema—Mesalazine—Crohn's disease	0.00369	0.00369	CcSEcCtD
Rifaximin—Malaise—Mesalazine—Crohn's disease	0.00364	0.00364	CcSEcCtD
Rifaximin—Vertigo—Mesalazine—Crohn's disease	0.00362	0.00362	CcSEcCtD
Rifaximin—Syncope—Mesalazine—Crohn's disease	0.00362	0.00362	CcSEcCtD
Rifaximin—Nausea—Mercaptopurine—Crohn's disease	0.0036	0.0036	CcSEcCtD
Rifaximin—Infection—Azathioprine—Crohn's disease	0.00359	0.00359	CcSEcCtD
Rifaximin—Loss of consciousness—Mesalazine—Crohn's disease	0.00354	0.00354	CcSEcCtD
Rifaximin—Cough—Mesalazine—Crohn's disease	0.00352	0.00352	CcSEcCtD
Rifaximin—Skin disorder—Azathioprine—Crohn's disease	0.00351	0.00351	CcSEcCtD
Rifaximin—Chest pain—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Rifaximin—Myalgia—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Rifaximin—Arthralgia—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00341	0.00341	CcSEcCtD
Rifaximin—Discomfort—Mesalazine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Rifaximin—Hypotension—Azathioprine—Crohn's disease	0.00338	0.00338	CcSEcCtD
Rifaximin—Dry mouth—Mesalazine—Crohn's disease	0.00336	0.00336	CcSEcCtD
Rifaximin—Confusional state—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00329	0.00329	CcSEcCtD
Rifaximin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00329	0.00329	CcSEcCtD
Rifaximin—Infection—Mesalazine—Crohn's disease	0.00327	0.00327	CcSEcCtD
Rifaximin—Shock—Mesalazine—Crohn's disease	0.00324	0.00324	CcSEcCtD
Rifaximin—Nervous system disorder—Mesalazine—Crohn's disease	0.00323	0.00323	CcSEcCtD
Rifaximin—Skin disorder—Mesalazine—Crohn's disease	0.0032	0.0032	CcSEcCtD
Rifaximin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00318	0.00318	CcSEcCtD
Rifaximin—Anorexia—Mesalazine—Crohn's disease	0.00314	0.00314	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00312	0.00312	CcSEcCtD
Rifaximin—Abdominal distension—Prednisone—Crohn's disease	0.00308	0.00308	CcSEcCtD
Rifaximin—Hypotension—Mesalazine—Crohn's disease	0.00308	0.00308	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.003	0.003	CcSEcCtD
Rifaximin—Sweating increased—Prednisone—Crohn's disease	0.00298	0.00298	CcSEcCtD
Rifaximin—Feeling abnormal—Azathioprine—Crohn's disease	0.00298	0.00298	CcSEcCtD
Rifaximin—Insomnia—Mesalazine—Crohn's disease	0.00298	0.00298	CcSEcCtD
Rifaximin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00295	0.00295	CcSEcCtD
Rifaximin—Dyspnoea—Mesalazine—Crohn's disease	0.00293	0.00293	CcSEcCtD
Rifaximin—Neutropenia—Prednisone—Crohn's disease	0.00286	0.00286	CcSEcCtD
Rifaximin—Decreased appetite—Mesalazine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Rifaximin—Abdominal pain—Azathioprine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Rifaximin—Body temperature increased—Azathioprine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Rifaximin—Fatigue—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Rifaximin—Pain—Mesalazine—Crohn's disease	0.00281	0.00281	CcSEcCtD
Rifaximin—Constipation—Mesalazine—Crohn's disease	0.00281	0.00281	CcSEcCtD
Rifaximin—Weight increased—Prednisone—Crohn's disease	0.00279	0.00279	CcSEcCtD
Rifaximin—Weight decreased—Prednisone—Crohn's disease	0.00277	0.00277	CcSEcCtD
Rifaximin—Hyperglycaemia—Prednisone—Crohn's disease	0.00276	0.00276	CcSEcCtD
Rifaximin—Depression—Prednisone—Crohn's disease	0.00272	0.00272	CcSEcCtD
Rifaximin—Feeling abnormal—Mesalazine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Rifaximin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00269	0.00269	CcSEcCtD
Rifaximin—Hypersensitivity—Azathioprine—Crohn's disease	0.00266	0.00266	CcSEcCtD
Rifaximin—Urticaria—Mesalazine—Crohn's disease	0.00261	0.00261	CcSEcCtD
Rifaximin—Abdominal pain—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Rifaximin—Body temperature increased—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Rifaximin—Diarrhoea—Azathioprine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Rifaximin—Haemoglobin—Prednisone—Crohn's disease	0.00246	0.00246	CcSEcCtD
Rifaximin—Haemorrhage—Prednisone—Crohn's disease	0.00245	0.00245	CcSEcCtD
Rifaximin—Hypersensitivity—Mesalazine—Crohn's disease	0.00242	0.00242	CcSEcCtD
Rifaximin—Dizziness—Azathioprine—Crohn's disease	0.00239	0.00239	CcSEcCtD
Rifaximin—Asthenia—Mesalazine—Crohn's disease	0.00236	0.00236	CcSEcCtD
Rifaximin—Pruritus—Mesalazine—Crohn's disease	0.00233	0.00233	CcSEcCtD
Rifaximin—Vomiting—Azathioprine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Rifaximin—Rash—Azathioprine—Crohn's disease	0.00228	0.00228	CcSEcCtD
Rifaximin—Dermatitis—Azathioprine—Crohn's disease	0.00228	0.00228	CcSEcCtD
Rifaximin—Flushing—Prednisone—Crohn's disease	0.00227	0.00227	CcSEcCtD
Rifaximin—Headache—Azathioprine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Rifaximin—Diarrhoea—Mesalazine—Crohn's disease	0.00225	0.00225	CcSEcCtD
Rifaximin—Angiopathy—Prednisone—Crohn's disease	0.00222	0.00222	CcSEcCtD
Rifaximin—Dizziness—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Rifaximin—Mental disorder—Prednisone—Crohn's disease	0.00215	0.00215	CcSEcCtD
Rifaximin—Nausea—Azathioprine—Crohn's disease	0.00215	0.00215	CcSEcCtD
Rifaximin—Malnutrition—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Rifaximin—Vomiting—Mesalazine—Crohn's disease	0.00209	0.00209	CcSEcCtD
Rifaximin—Rash—Mesalazine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Rifaximin—Dermatitis—Mesalazine—Crohn's disease	0.00207	0.00207	CcSEcCtD
Rifaximin—Headache—Mesalazine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Rifaximin—Ill-defined disorder—Prednisone—Crohn's disease	0.00198	0.00198	CcSEcCtD
Rifaximin—Anaemia—Prednisone—Crohn's disease	0.00197	0.00197	CcSEcCtD
Rifaximin—Nausea—Mesalazine—Crohn's disease	0.00196	0.00196	CcSEcCtD
Rifaximin—Angioedema—Prednisone—Crohn's disease	0.00195	0.00195	CcSEcCtD
Rifaximin—Malaise—Prednisone—Crohn's disease	0.00192	0.00192	CcSEcCtD
Rifaximin—Vertigo—Prednisone—Crohn's disease	0.00192	0.00192	CcSEcCtD
Rifaximin—Syncope—Prednisone—Crohn's disease	0.00191	0.00191	CcSEcCtD
Rifaximin—Loss of consciousness—Prednisone—Crohn's disease	0.00188	0.00188	CcSEcCtD
Rifaximin—Arthralgia—Prednisone—Crohn's disease	0.00182	0.00182	CcSEcCtD
Rifaximin—Myalgia—Prednisone—Crohn's disease	0.00182	0.00182	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.0018	0.0018	CcSEcCtD
Rifaximin—Discomfort—Prednisone—Crohn's disease	0.00179	0.00179	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisone—Crohn's disease	0.00174	0.00174	CcSEcCtD
Rifaximin—Infection—Prednisone—Crohn's disease	0.00173	0.00173	CcSEcCtD
Rifaximin—Shock—Prednisone—Crohn's disease	0.00171	0.00171	CcSEcCtD
Rifaximin—Nervous system disorder—Prednisone—Crohn's disease	0.00171	0.00171	CcSEcCtD
Rifaximin—Skin disorder—Prednisone—Crohn's disease	0.00169	0.00169	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisone—Crohn's disease	0.00168	0.00168	CcSEcCtD
Rifaximin—Anorexia—Prednisone—Crohn's disease	0.00166	0.00166	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00159	0.00159	CcSEcCtD
Rifaximin—Insomnia—Prednisone—Crohn's disease	0.00158	0.00158	CcSEcCtD
Rifaximin—Decreased appetite—Prednisone—Crohn's disease	0.00151	0.00151	CcSEcCtD
Rifaximin—Fatigue—Prednisone—Crohn's disease	0.0015	0.0015	CcSEcCtD
Rifaximin—Constipation—Prednisone—Crohn's disease	0.00149	0.00149	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisone—Crohn's disease	0.00144	0.00144	CcSEcCtD
Rifaximin—Gastrointestinal pain—Prednisone—Crohn's disease	0.00142	0.00142	CcSEcCtD
Rifaximin—Urticaria—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Rifaximin—Abdominal pain—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Rifaximin—Body temperature increased—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisone—Crohn's disease	0.00128	0.00128	CcSEcCtD
Rifaximin—Asthenia—Prednisone—Crohn's disease	0.00125	0.00125	CcSEcCtD
Rifaximin—Pruritus—Prednisone—Crohn's disease	0.00123	0.00123	CcSEcCtD
Rifaximin—Diarrhoea—Prednisone—Crohn's disease	0.00119	0.00119	CcSEcCtD
Rifaximin—Dizziness—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Rifaximin—Vomiting—Prednisone—Crohn's disease	0.00111	0.00111	CcSEcCtD
Rifaximin—Rash—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Rifaximin—Dermatitis—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Rifaximin—Headache—Prednisone—Crohn's disease	0.00109	0.00109	CcSEcCtD
Rifaximin—Nausea—Prednisone—Crohn's disease	0.00103	0.00103	CcSEcCtD
